| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.1987.01800150060008 |
| P698 | PubMed publication ID | 3103580 |
| P50 | author | Robert D. Gibbons | Q46996511 |
| P2093 | author name string | Fawcett J | |
| Clark DC | |||
| McGuire M | |||
| Pisani VD | |||
| Sellers D | |||
| Aagesen CA | |||
| Tilkin JM | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alcoholism | Q15326 |
| placebo | Q269829 | ||
| placebo-controlled trial | Q108853737 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 248-256 | |
| P577 | publication date | 1987-03-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism | |
| P478 | volume | 44 |
| Q36685249 | A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. |
| Q44455169 | Acamprosate and its efficacy in treating alcohol dependent adolescents |
| Q72777212 | Alcoholism |
| Q58178770 | Comparison of Naltrexone and Placebo in Treatment of Alcohol Dependence of Adolescents |
| Q71177254 | Comparison of acamprosate and placebo in long-term treatment of alcohol dependence |
| Q34521351 | Current research on rapid cycling bipolar disorder and its treatment |
| Q38758442 | Drug Interactions with Lithium: An Update |
| Q41221739 | Drugs to decrease alcohol drinking |
| Q67855244 | Lithium Carbonate and Mood Disorder in Recently Detoxified Alcoholics: A Double-Blind, Placebo-Controlled Pilot Study |
| Q91666918 | Medications for Treating Alcoholism |
| Q37810013 | New applications of lithium therapy |
| Q41199428 | New methodologies for pharmacological treatment trials for alcohol dependence |
| Q51715941 | Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report |
| Q39409302 | Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder. |
| Q35860671 | Pharmacological treatment of alcoholism |
| Q38658672 | Pharmacological treatment of schizophrenia with comorbid substance use disorder. |
| Q37414960 | Pharmacotherapies for alcoholism: promising agents and clinical issues |
| Q41560119 | Pharmacotherapy of alcohol dependence |
| Q35677411 | Pharmacotherapy of alcohol use disorders: seventy-five years of progress |
| Q68360832 | Platelet monoamine oxidase in alcoholism |
| Q37209634 | Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents |
| Q54114245 | Recent progress in the study of alcoholism |
| Q39465797 | The feasibility of effective psychopharmacological treatments for alcoholism |
| Q55887262 | The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls |
| Q34458957 | The life‐time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls |
| Q37702370 | The strong relationship between bipolar and substance-use disorder |
Search more.